Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Muhammad Affan Abid
Institution:
Dow University of Health Sciences
Observed institution:
Dow University of Health Sciences
ORCID:
0009-0002-0033-7028
Observed ORCID:
0009-0002-0033-7028
OpenAlex ID:
A5114099063
Natural Peptides Versus Semaglutide: A Safer Approach to Obesity Management
2025
·
Muhammad Affan Abid
, Muhammad Babar Asad
, et al.
·
Medicine Advances
·
1
PDF
Stapled versus hand-sewn intestinal anastomosis in pediatric surgery: A systematic review and meta-analysis
2026
·
Muhammad Meeran Saleem
, Areeba Ahsan
, et al.
·
Journal of Pediatric Surgery
Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition
2025
·
Muhammad Affan Abid
, Malaika Manzoor
, et al.
·
Medicine Advances
PDF
Tenosynovial Giant Cell Tumor Treatment Revolution: Vimseltinib's Edge Over Pexidartinib
2025
·
Muhammad Affan Abid
, Syed Azfar Hussain
, et al.
·
Medicine Advances
PDF
Comparison of Adverse Effects of Combination Therapy of Mpox With Tecovirimat and Brincidofovir, and Individual Therapy With Tecovirimat
2025
·
Muhammad Affan Abid
, Abdul Ahad
, et al.
·
Medicine Advances
Vimkunya - Hope Against Chikungunya: Science, Safety, and Access.
2025
·
Muhammad Affan Abid
, Ashmat Naqvi
, et al.
·
PubMed
Scorching Heat and Fragile Hearts: Hidden Cardiovascular Risks
2024
·
Saim Mahmood Khan
, Mahnoor Ishaque
, et al.
·
Balkan Medical Journal
PDF
Show more works
View as search
Works count:
7
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
